Biotest AG

Patent cliffs & loss of exclusivity

Information on stock, financials, earnings, subsidiaries, investors, and executives for Biotest. Use the PitchBook Platform to explore the full profile.

Company

Legal NameBiotest AG
Company Operating StatusActive
Crunchbase URLhttps://www.crunchbase.com/organization/biotest-ag-2
Facebook URLhttps://www.facebook.com/biotest-ag-622320914576725/
Instagram URLhttps://www.instagram.com/pitchbookdata/
LinkedIn URLhttps://www.linkedin.com/company/biotest-ag
Pitchbook URLhttps://pitchbook.com/profiles/company/61065-91#overview
Twitter URLhttps://twitter.com/pitchbook

3 upcoming patent cliffs

DrugIngredientTypeCliff
  1. YIMMUGOimmune globulin intravenous, human-diraBiologicJun 2036
  2. YIMMUGOimmune globulin intravenous, human-diraBiologicJun 2036
  3. YIMMUGOimmune globulin intravenous, human-diraBiologicJun 2036

Loss-of-exclusivity dates are derived from the FDA Orange & Purple Books; company detail is from the CliffBio graph. Estimates are projections, not legal advice.

Biotest AG — patent cliffs & loss of exclusivity | CliffBio